An International, Randomized, Double-blind, Placebo-Controlled Phase 3 Trial of Intramuscular Alefacept in Patients With Chronic Plaque Psoriasis — Mark Lebwohl (2003) | RDL Network
An International, Randomized, Double-blind, Placebo-Controlled Phase 3 Trial of Intramuscular Alefacept in Patients With Chronic Plaque Psoriasis
Article 2003 en
Authors
ML
Mark Lebwohl
EC
Enno Christophers
RL
Richard G. Langley
Abstract
1 min read
Intramuscular administration of alefacept was a well-tolerated and effective therapy for chronic plaque psoriasis and thus represents a convenient alternative to intravenous dosing.
Tran Tinh Hien, Nguyen Hoan Phu, Nguyen Thi Hoang, Tran Thi Hong Chau, Tran Thi My Trang, Pham Phu Loc, Bui Minh Cuong, Nguyen The Dung, Ha Vinh, Deborah J Waller, Sir Nicholas White
Transactions of the Royal Society of Tropical Medicine and Hygiene
Alice B. Gottlieb, Christopher Em Griffiths, Vincent Ho, M. Lahfa, Ulrich Mrowietz, Dédée F. Murrell, Ortonne Jp, Gail Todd, Robert Cherill, I. N. Marks, Shahram Emady‐Azar, C. Paul
M. Bhushan, T.O. Bleiker, A. E. Ballsdon, Michael H. Allen, Mark Sopwith, M K Robinson, Cosmos C. Clarke, Richard Weller, R.A.C. GRAHAM-BROWN, M. Keefe, Juliet N. Barker, Christopher Em Griffiths
Valerie J. Ludbrook, Kirsty Hicks, Kate Hanrott, Jatin Patel, Michael Binks, Melody Wyres, Joanna Watson, Phebe Wilson, Monica Simeoni, Lorrie Schifano, Kristian Reich, Christopher Em Griffiths
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.